Eisai, Arena release Belviq XR weight-loss tablets
WOODCLIFF LAKE, N.J. and SAN DIEGO — Eisai Inc. and Arena Pharmaceuticals Inc. have launched Belviq XR (lorcaserin HCl) CIV extended-release 20-mg tablets, a weight-loss medication. The companies said Belviq XR, approved by the Food and Drug Administration in July, offers a new once-daily dosing option that may help some patients achieve and maintain weight
